Mechanistic investigations into interactions between IGF-I and IGFBPs and their impact on facilitating cell migration on vitronectin

References

• Abrass CK, Berfield AK, Andress DL. 1997. Heparin binding domain of insulin-like growth factor binding protein-5 stimulates mesangial cell migration. Am J Physiol. 273 6 Pt 2: F899–F906.
   Google Scholar
• Ainscough SL, Barnard Z, Upton Z, Harkin DG. 2006. Vitronectin supports migratory responses of corneal epithelial cells to substrate bound IGF-I and HGF, and facilitates serum-free cultivation. Exp Eye Res. 83 6: 1505–1514.
   PubMed Web of Science ®Google Scholar
• Arai T, Busby WJr., Clemmons DR. 1996. Binding of insulin-like growth factor (IGF) I or II to IGF-binding protein-2 enables it to bind to heparin and extracellular matrix. Endocrinology. 137 11: 4571–4575.
   PubMed Web of Science ®Google Scholar
• Booth BA, Boes M, Andress DL, Dake BL, Kiefer MC, Maack C, Linhardt RJ, Bar K, Caldwell EE, Weiler J, Bar RS. 1995. IGFBP-3 and IGFBP-5 association with endothelial cells: Role of C-terminal heparin binding domain. Growth Regul. 5 1: 1–17.
   PubMedGoogle Scholar
• Brooks PC, Klemke RL, Schon S, Lewis JM, Schwartz MA, Cheresh DA. 1997. Insulin-like growth factor receptor cooperates with integrin alpha v beta 5 to promote tumor cell dissemination in vivo. J Clin Invest. 99 6: 1390–1398.
   PubMed Web of Science ®Google Scholar
• Burrows C, Holly JM, Laurence NJ, Vernon EG, Carter JV, Clark MA, McIntosh J, McCaig C, Winters ZE, Perks CM. 2006. Insulin-like growth factor binding protein 3 has opposing actions on malignant and nonmalignant breast epithelial cells that are each reversible and dependent upon cholesterol-stabilized integrin receptor complexes. Endocrinology. 147 7: 3484–3500.
   PubMed Web of Science ®Google Scholar
• Camacho-Hubner C, Busby WHJr., McCusker RH, Wright G, Clemmons DR. 1992. Identification of the forms of insulin-like growth factor-binding proteins produced by human fibroblasts and the mechanisms that regulate their secretion. J Biol Chem. 267 17: 11949–11956.
   PubMed Web of Science ®Google Scholar
• Campbell PG, Durham SK, Suwanichkul A, Hayes JD, Powell DR. 1998. Plasminogen binds the heparin-binding domain of insulin-like growth factor-binding protein-3. Am J Physiol. 275 2 Pt 1: E321–E331.
   Google Scholar
• Clemmons DR, Maile LA. 2005. Interaction between insulin-like growth factor-I receptor and alphaVbeta3 integrin linked signaling pathways: Cellular responses to changes in multiple signaling inputs. Mol Endocrinol. 19 1: 1–11.
   PubMed Web of Science ®Google Scholar
• Dawson RA, Upton Z, Malda J, Harkin DG. 2006. Preparation of cultured skin for transplantation using insulin-like growth factor I in conjunction with insulin-like growth factor binding protein 5, epidermal growth factor, and vitronectin. Transplantation. 81 12: 1668–1676.
   PubMed Web of Science ®Google Scholar
• Doerr ME, Jones JI. 1996. The roles of integrins and extracellular matrix proteins in the insulin-like growth factor I-stimulated chemotaxis of human breast cancer cells. J Biol Chem. 271 5: 2443–2447.
   PubMed Web of Science ®Google Scholar
• Eliceiri BP. 2001. Integrin and growth factor receptor crosstalk. Circ Res. 89 12: 1104–1110.
   PubMed Web of Science ®Google Scholar
• Fu P, Thompson JA, Bach LA. 2007. Promotion of cancer cell migration: An insulin-like growth factor (IGF)-independent action of IGF-binding protein-6. J Biol Chem. 282 31: 22298–22306.
   PubMed Web of Science ®Google Scholar
• Giancotti FG, Ruoslahti E. 1999. Integrin signaling. Science. 285 5430: 1028–1032.
   PubMed Web of Science ®Google Scholar
• Gockerman A, Prevette T, Jones JI, Clemmons DR. 1995. Insulin-like growth factor (IGF)-binding proteins inhibit the smooth muscle cell migration responses to IGF-I and IGF-II. Endocrinology. 136 10: 4168–4173.
   PubMed Web of Science ®Google Scholar
• Gui Y, Murphy LJ. 2001. Insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) binds to fibronectin (FN): Demonstration of IGF-I/IGFBP-3/fn ternary complexes in human plasma. J Clin Endocrinol Metab. 86 5: 2104–2110.
   PubMed Web of Science ®Google Scholar
• Hamilton GS, Lysiak JJ, Han VK, Lala PK. 1998. Autocrine-paracrine regulation of human trophoblast invasiveness by insulin-like growth factor (IGF)-II and IGF-binding protein (IGFBP)-1. Exp Cell Res. 244 1: 147–156.
   PubMed Web of Science ®Google Scholar
• Hollier B, Harkin DG, Leavesley D, Upton Z. 2005. Responses of keratinocytes to substrate-bound vitronectin: Growth factor complexes. Exp Cell Res. 305 1: 221–232.
   PubMed Web of Science ®Google Scholar
• Hollier BG, Kricker JA, Van Lonkhuyzen DR, Leavesley DI, Upton Z. 2008. Substrate-bound insulin-like growth factor (IGF)-I-IGF binding protein-vitronectin-stimulated breast cell migration is enhanced by coactivation of the phosphatidylinositide 3-Kinase/AKT pathway by alphav-integrins and the IGF-I receptor. Endocrinology. 149 3: 1075–1090.
   PubMed Web of Science ®Google Scholar
• Hsieh T, Gordon RE, Clemmons DR, Busby WHJr., Duan C. 2003. Regulation of vascular smooth muscle cell responses to insulin-like growth factor (IGF)-I by local IGF-binding proteins. J Biol Chem. 278 44: 42886–42892.
   PubMed Web of Science ®Google Scholar
• Hyde C, Hollier B, Anderson A, Harkin D, Upton Z. 2004. Insulin-like growth factors (IGF) and IGF-binding proteins bound to vitronectin enhance keratinocyte protein synthesis and migration. J Invest Dermatol. 122 5: 1198–1206.
   PubMed Web of Science ®Google Scholar
• Jones JI, Gockerman A, Busby WHJr., Camacho-Hubner C, Clemmons DR. Extracellular matrix contains insulin-like growth factor binding protein-5: Potentiation of the effects of IGF-I. J Cell Biol. 1993a; 121 3: 679–687.
   PubMed Web of Science ®Google Scholar
• Jones JI, Gockerman A, Busby WHJr., Wright G, Clemmons DR. Insulin-like growth factor binding protein 1 stimulates cell migration and binds to the alpha 5 beta 1 integrin by means of its Arg-Gly-Asp sequence. Proc Natl Acad Sci USA. 1993b; 90 22: 10553–10557.
   PubMed Web of Science ®Google Scholar
• Koivisto L, Larjava K, Hakkinen L, Uitto VJ, Heino J, Larjava H. 1999. Different integrins mediate cell spreading, haptotaxis and lateral migration of HaCaT keratinocytes on fibronectin. Cell Adhes Commun. 7 3: 245–257.
   PubMed Web of Science ®Google Scholar
• Kricker JA, Towne CL, Firth SM, Herington AC, Upton Z. 2003. Structural and functional evidence for the interaction of insulin-like growth factors (IGFs) and IGF binding proteins with vitronectin. Endocrinology. 144 7: 2807–2815.
   PubMed Web of Science ®Google Scholar
• Labat-Robert J, Bihari-Varga M, Robert L. 1990. Extracellular matrix. FEBS Lett. 268 2: 386–393.
   PubMed Web of Science ®Google Scholar
• Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227 5259: 680–685.
   PubMed Web of Science ®Google Scholar
• Larsen M, Artym VV, Green JA, Yamada KM. 2006. The matrix reorganized: Extracellular matrix remodeling and integrin signaling. Curr Opin Cell Biol. 18 5: 463–471.
   PubMed Web of Science ®Google Scholar
• Leavesley DI, Schwartz MA, Rosenfeld M, Cheresh DA. 1993. Integrin beta 1- and beta 3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J Cell Biol. 121 1: 163–170.
   PubMed Web of Science ®Google Scholar
• LeRoith D, Roberts CTJr. 2003. The insulin-like growth factor system and cancer. Cancer Lett. 195 2: 127–137.
   PubMed Web of Science ®Google Scholar
• Maile LA, Busby WH, Sitko K, Capps BE, Sergent T, Badley-Clarke J, Clemmons DR. Insulin-like growth factor-I signaling in smooth muscle cells is regulated by ligand binding to the 177CYDMKTTC184 sequence of the beta3-subunit of alphaVbeta3. Mol Endocrinol. 2006a; 20 2: 405–413.
   PubMedGoogle Scholar
• Maile LA, Busby WH, Sitko K, Capps BE, Sergent T, Badley-Clarke J, Ling Y, Clemmons DR. The heparin binding domain of vitronectin is the region that is required to enhance insulin-like growth factor-I signaling. Mol Endocrinol. 2006b; 20 4: 881–892.
   PubMedGoogle Scholar
• Martin JA, Buckwalter JA. 2000. The role of chondrocyte-matrix interactions in maintaining and repairing articular cartilage. Biorheology. 37 1–2: 129–140.
   PubMed Web of Science ®Google Scholar
• Martin JL, Jambazov S. 2006. Insulin-like growth factor binding protein-3 in extracellular matrix stimulates adhesion of breast epithelial cells and activation of p44/42 mitogen-activated protein kinase. Endocrinology. 147 9: 4400–4409.
   PubMed Web of Science ®Google Scholar
• Massoner P, Colleselli D, Matscheski A, Pircher H, Geley S, Jansen Durr P, Klocker H. 2009. Novel mechanism of IGF-binding protein-3 action on prostate cancer cells: Inhibition of proliferation, adhesion, and motility. Endocr Relat Cancer. 16 3: 795–808.
   PubMed Web of Science ®Google Scholar
• Nam T, Moralez A, Clemmons D. 2002. Vitronectin binding to IGF binding protein-5 (IGFBP-5) alters IGFBP-5 modulation of IGF-I actions. Endocrinology. 143 1: 30–36.
   PubMed Web of Science ®Google Scholar
• Nathan C, Sporn M. 1991. Cytokines in context. J Cell Biol. 113 5: 981–986.
   PubMed Web of Science ®Google Scholar
• Noble A, Towne C, Chopin L, Leavesley D, Upton Z. 2003. Insulin-like growth factor-II bound to vitronectin enhances MCF-7 breast cancer cell migration. Endocrinology. 144 6: 2417–2424.
   PubMed Web of Science ®Google Scholar
• Parker A, Clarke JB, Busby WHJr., Clemmons DR. 1996. Identification of the extracellular matrix binding sites for insulin-like growth factor-binding protein 5. J Biol Chem. 271 23: 13523–13529.
   PubMed Web of Science ®Google Scholar
• Parker A, Rees C, Clarke J, Busby WHJr., Clemmons DR. 1998. Binding of insulin-like growth factor (IGF)-binding protein-5 to smooth-muscle cell extracellular matrix is a major determinant of the cellular response to IGF-I. Mol Biol Cell. 9 9: 2383–2392.
   PubMed Web of Science ®Google Scholar
• Richards S, Leavesley D, Topping G, Upton Z. 2008. Development of defined media for the serum-free expansion of primary keratinocytes and human embryonic stem cells. Tissue Eng Part C Methods. 14 3: 221–232.
   PubMed Web of Science ®Google Scholar
• Ruoslahti E. 1989. Proteoglycans in cell regulation. J Biol Chem. 264 23: 13369–13372.
   PubMed Web of Science ®Google Scholar
• Samani AA, Yakar S, LeRoith D, Brodt P. 2007. The role of the IGF system in cancer growth and metastasis: Overview and recent insights. Endocr Rev. 28 1: 20–47.
   PubMed Web of Science ®Google Scholar
• Schleicher I, Parker A, Leavesley D, Crawford R, Upton Z, Xiao Y. 2005. Surface modification by complexes of vitronectin and growth factors for serum-free culture of human osteoblasts. Tissue Eng. 11 11–12: 1688–1698.
   PubMedGoogle Scholar
• Schutt BS, Langkamp M, Rauschnabel U, Ranke MB, Elmlinger MW. 2004. Integrin-mediated action of insulin-like growth factor binding protein-2 in tumor cells. J Mol Endocrinol. 32 3: 859–868.
   PubMed Web of Science ®Google Scholar
• Tissue Therapies Ltd. 2009. ASX Announcement: Excellent VitroGro® Results: Australian Human Trial. Available from http://www.tissuetherapies.com/investors/091123%20TIS%20ASX%20Aust%20Results%20Final.pdf.
   Google Scholar
• Towbin H, Staehelin T, Gordon J. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA. 76 9: 4350–4354.
   PubMed Web of Science ®Google Scholar
• Upton Z, Cuttle L, Noble A, Kempf M, Topping G, Malda J, Xie Y, Mill J, Harkin DG, Kravchuk O, Leavesley DI, Kimble RM. 2008. Vitronectin: Growth factor complexes hold potential as a wound therapy approach. J Invest Dermatol. 128 6: 1535–1544.
   PubMed Web of Science ®Google Scholar
• Upton Z, Webb H, Hale K, Yandell CA, McMurtry JP, Francis GL, Ballard FJ. 1999. Identification of vitronectin as a novel insulin-like growth factor-II binding protein. Endocrinology. 140 6: 2928–2931.
   PubMed Web of Science ®Google Scholar
• Wang GK, Hu L, Fuller GN, Zhang W. 2006. An interaction between insulin-like growth factor-binding protein 2 (IGFBP2) and integrin alpha5 is essential for IGFBP2-induced cell mobility. J Biol Chem. 281 20: 14085–14091.
   PubMed Web of Science ®Google Scholar